## Abstract ## Background Disease relapse is the leading cause of mortality for children diagnosed with disseminated neuroblastoma. The adoptive transfer of tumor‐specific T cells is an attractive approach to target minimal residual disease following conventional therapies. We describe here the ge
Prospects for adoptive T cell therapy
✍ Scribed by Cassian Yee; Stanley R Riddell; Philip D Greenberg
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 796 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0952-7915
No coin nor oath required. For personal study only.
✦ Synopsis
Since the establishment of methods to isolate genes encoding cytotoxic T lymphocyte defined tumor antigens, several antigens have been identified and characterized for suitability as target antigens for immunotherapy. The development of innovative strategies to generate T cells targeting these antigens and lessons learned from clinical trials of adoptive immunotherapy of viral diseases should facilitate the design of clinical trials for specific adoptive immunotherapy of cancer.
📜 SIMILAR VOLUMES
## Abstract Adoptive transfer of antigen‐specific T‐cells has shown therapeutic successes in the treatment of tumors in patients with metastatic melanoma. Tumor antigen‐specific T‐lymphocytes, however, occur only at low frequencies in a small proportion of patients. This low T‐lymphocyte frequency
## Abstract The lack of efficient T‐cell infiltration of tumors is a major obstacle to successful adoptive T‐cell therapy. We have previously demonstrated that adenovirus (AdV)‐mediated transgene lymphotactin (Lptn) or IP‐10 expression in tumors can significantly enhance T‐cell tumor infiltration.
The goal of this review is to provide an overview of gene delivery systems and candidate genes currently being evaluated for genetic strategies in vascular gene therapy. We will discuss treatment strategies that have been shown by in vivo model systems to be efficacious in promoting neovascularizati